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Introduction
42
Antibiotics in dairy cattle are mainly used to treat mastitis, diarrhoea and 43 pulmonary diseases (McEwen & Fedorka-Cray, 2002) . These treatments can result in 44 the presence of antibiotic residues in milk. For consumers, the presence of such residues 45 can be responsible for toxic effects, allergic reactions in individuals with 46 hypersensitivity, and can result in the development of resistant strains of bacteria (Barlow, 2011; Knecht et al., 2004; Toldrá & Reig, 2006; Wassenaar, 2005) . The 48 presence of antibiotic residues can also be responsible for undesirable effects in the 49 dairy industry, especially concerning processed food by fermentation wherein the 50 quality of the final products can be seriously compromised (Toldrá & Reig, 2006) . All 51 these concerns make the analysis of antibiotic residues in milk an important field of 52 food safety to study.
53
To protect consumers, regulatory agencies in the European Union published 54 several official documents regulating the control of veterinary drugs in food products 55 from animal origin. Council Directive 96/23/EC (European Commission, 1996) 56 establishes the veterinary residue control in food producing animals. Tolerance levels,
as described by European Commission Regulation 470/2009/EC (European
58
Commission, 2009), were set for compounds that can be used for therapeutic purposes. well as compounds for which no MRL has been set because no hazard for public health 62 has been observed. For some non-authorised substances a minimum required 63 performance limit (MRPL) was set to harmonise the analytical performance of the M A N U S C R I P T
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4 methods (SANCO, 2007; European Commission, 2002) Table 1 .
131
The UPLC system consisted of a vacuum degasser, an autosampler and a binary difficult to find one with multi-class selectivity.
196
A procedure using a polymeric sorbent SPE cartridge, composed of an OASIS® banned substance, has to be detected at very low concentrations below its corresponding 216 MRPL at 0.3 µg kg -1 , which was successfully achieved (LOD = 0.06 µg kg -1 ; Table 2 ).
217
To achieve maximum sensitivity for all compounds, MS/MS conditions (such as 218 ion spray voltage, de-solvation temperature, and gas flow and collision conditions) were 219 optimised by direct infusion into the detector of standard solutions and the principal ion 220 transition was selected for each analyte. Table 1 
235
The main requisite for a reliable screening method is to detect unauthorised 
248
The results for precision, quantified as RSD% ( that CCβ is the smallest content of the substance that may be detected, identified and/or 254 quantified in a sample with an error probability of β=5%, it is considered to be the 255 concentration above which the sample should be re-analysed by a confirmatory method 256 for screening purposes. It is also stated that CCβ must be less than or equal to the Table 2 . M A N U S C R I P T 
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